Aarkstore.com announces, The Latest market research report is available inits vast collection:Ocular Pain – Pipeline Review, H1 2012You can also request for sample page of above mention reports email@example.comSummaryGlobal Markets Direct’s, Ocular Pain - Pipeline Review, H1 2012, provides anoverview of the Ocular Pain therapeutic pipeline. This report provides informationon the therapeutic development for Ocular Pain, complete with latest updates, andspecial features on late-stage and discontinued projects. It also reviews key playersinvolved in the therapeutic development for Ocular Pain. Ocular Pain - PipelineReview, H1 2012 is built using data and information sourced from Global MarketsDirect’s proprietary databases, Company/University websites, SEC filings, investorpresentations and featured press releases from company/university sites andindustry-specific third party sources, put together by Global Markets Direct’s team.Note*: Certain sections in the report may be removed or altered based on theavailability and relevance of data for the indicated disease.Scope- A snapshot of the global therapeutic scenario for Ocular Pain.- A review of the Ocular Pain products under development by companies anduniversities/research institutes based on information derived from company andindustry-specific sources.- Coverage of products based on various stages of development ranging fromdiscovery till registration stages.- A feature on pipeline projects on the basis of monotherapy and combinedtherapeutics.
Table of contents:List of Tables 4List of Figures 4Introduction 5Global Markets Direct Report Coverage 5Ocular Pain Overview 6Therapeutics Development 7An Overview of Pipeline Products for Ocular Pain 7Ocular Pain Therapeutics under Development by Companies 9Late Stage Products 10Comparative Analysis 10Mid Clinical Stage Products 11Comparative Analysis 11Early Clinical Stage Products 12Comparative Analysis 12Pre-Clinical Stage Products 13Comparative Analysis 13Ocular Pain Therapeutics – Products under Development by Companies 14Companies Involved in Ocular Pain Therapeutics Development 15Sylentis 15Novagali Pharma SA 16ISTA Pharmaceuticals, Inc. 17InSite Vision Incorporated 18Ocular Pain – Therapeutics Assessment 19Assessment by Monotherapy Products 19Assessment by Route of Administration 20Assessment by Molecule Type 22Drug Profiles 24BromSite - Drug Profile 24Product Description 24Mechanism of Action 24R&D Progress 24Nova-22038 - Drug Profile 25Product Description 25
List of FiguresList of Tables are also include.For more related Reports Plz follow The link:Pipeline Review, H1 2012http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H12012&PubId=&pagenum=1Refractory Angina – Pipeline Review, H1 2012Post-Myocardial Infarction – Pipeline Review, H1 2012Proteinuria – Pipeline Review, H1 2012Ocular Pain – Pipeline Review, H1 2012Pediculosis (Head Lice Infestation) – Pipeline Review, H1 2012Allergic Rhino-Conjunctivitis – Pipeline Review, H1 2012Acquired (Autoimmune) Hemolytic Anemia – Pipeline Review, H1 2012Thyroid Gland Disorders – Pipeline Review, H1 2012Tinea Corporis – Pipeline Review, H1 2012
Pulmonary Fibrosis – Pipeline Review, H1 2012Search More Reports Related to This Category :Pharmaceuticals and Healthcarehttp://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals andHealthcare&PubId=&pagenum=1For More details Plz do contact :Aarkstore EnterpriseLavanyaPhone:08149852585Email: firstname.lastname@example.org